| 1 | [SID124756817] | Active | IC50 | 41.8 | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase in an orthogonal kinetic assay utilizing the direct detection of NADPH [AID588593, Type: confirmatory] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 124756817 | | CID | 20885160 | | Outcome | Active | | IC50 | 41.8 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase in an orthogonal kinetic assay utilizing the direct detection of NADPH | | AID | 588593 | | BioAssay type | confirmatory | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 2 | [SID49649712] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 3 | [SID125264923] | Active | IC50 | 57.4 | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase in an orthogonal kinetic assay utilizing the direct detection of NADPH [AID588593, Type: confirmatory] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 125264923 | | CID | 20885160 | | Outcome | Active | | IC50 | 57.4 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase in an orthogonal kinetic assay utilizing the direct detection of NADPH | | AID | 588593 | | BioAssay type | confirmatory | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 4 | [SID124756817] | Active | IC50 | 67.3 | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase in an orthogonal assay utilizing the direct end-point detection of NADPH [AID588588, Type: confirmatory] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 124756817 | | CID | 20885160 | | Outcome | Active | | IC50 | 67.3 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase in an orthogonal assay utilizing the direct end-point detection of NADPH | | AID | 588588 | | BioAssay type | confirmatory | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 5 | [SID125264923] | Active | IC50 | 69.8 | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase in an orthogonal assay utilizing the direct end-point detection of NADPH [AID588588, Type: confirmatory] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 125264923 | | CID | 20885160 | | Outcome | Active | | IC50 | 69.8 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase in an orthogonal assay utilizing the direct end-point detection of NADPH | | AID | 588588 | | BioAssay type | confirmatory | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 6 | [SID49649712] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 7 | [SID49649712] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 8 | [SID49649712] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 9 | [SID49649712] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 10 | [SID49649712] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 11 | [SID49649712] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 12 | [SID49649712] | Inactive | Potency | 28.1838 | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy [AID624291, Type: confirmatory] | Glycoprotein hormones alpha chain [gi:121312] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy | | AID | 624291 | | BioAssay type | confirmatory | | Target | Glycoprotein hormones alpha chain [gi:121312] | | PubMed | | | Data Table |  |
|
| 13 | [SID125264923] | Inactive | IC50 | 44.6 | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay - Set 2 [AID588671, Type: confirmatory] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 125264923 | | CID | 20885160 | | Outcome | Inactive | | IC50 | 44.6 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay - Set 2 | | AID | 588671 | | BioAssay type | confirmatory | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 14 | [SID124756817] | Inactive | IC50 | 54.5 | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay [AID588415, Type: confirmatory] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 124756817 | | CID | 20885160 | | Outcome | Inactive | | IC50 | 54.5 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay | | AID | 588415 | | BioAssay type | confirmatory | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 15 | [SID124756817] | Inactive | IC50 | 80 | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase using a Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay [AID588414, Type: confirmatory] | G6PD gene product [Homo sapiens] [gi:108773793] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 124756817 | | CID | 20885160 | | Outcome | Inactive | | IC50 | 80 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase using a Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay | | AID | 588414 | | BioAssay type | confirmatory | | Target | G6PD gene product [Homo sapiens] [gi:108773793] | | PubMed | | | Data Table |  |
|
| 16 | [SID124756817] | Inactive | IC50 | 80 | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase using a Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay [AID588414, Type: confirmatory] | G6PD gene product [Homo sapiens] [gi:108773793] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 124756817 | | CID | 20885160 | | Outcome | Inactive | | IC50 | 80 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase using a Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay | | AID | 588414 | | BioAssay type | confirmatory | | Target | G6PD gene product [Homo sapiens] [gi:108773793] | | PubMed | | | Data Table |  |
|
| 17 | [SID125264923] | Inactive | IC50 | 80 | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase using a Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay - Set 2 [AID588672, Type: confirmatory] | G6PD gene product [Homo sapiens] [gi:108773793] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 125264923 | | CID | 20885160 | | Outcome | Inactive | | IC50 | 80 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase using a Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay - Set 2 | | AID | 588672 | | BioAssay type | confirmatory | | Target | G6PD gene product [Homo sapiens] [gi:108773793] | | PubMed | | | Data Table |  |
|
| 18 | [SID125264923] | Inactive | IC50 | 80 | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase using a Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay - Set 2 [AID588672, Type: confirmatory] | G6PD gene product [Homo sapiens] [gi:108773793] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 125264923 | | CID | 20885160 | | Outcome | Inactive | | IC50 | 80 [uM] | | BioAssay | SAR analysis of small molecule inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase using a Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay - Set 2 | | AID | 588672 | | BioAssay type | confirmatory | | Target | G6PD gene product [Homo sapiens] [gi:108773793] | | PubMed | | | Data Table |  |
|
| 19 | [SID49649712] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 20 | [SID49649712] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 21 | [SID49649712] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 22 | [SID49649712] | Inactive | Potency | | qHTS Assay for Inhibitors of Human Galactokinase (GALK) [AID1868, Type: confirmatory] | galactokinase [Homo sapiens] [gi:4503895] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Galactokinase (GALK) | | AID | 1868 | | BioAssay type | confirmatory | | Target | galactokinase [Homo sapiens] [gi:4503895] | | PubMed | | | Data Table |  |
|
| 23 | [SID49649712] | Inactive | Potency | | qHTS Assay for Inhibitors of Human Galactokinase (GALK) [AID1868, Type: confirmatory] | galactokinase [Homo sapiens] [gi:4503895] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Galactokinase (GALK) | | AID | 1868 | | BioAssay type | confirmatory | | Target | galactokinase [Homo sapiens] [gi:4503895] | | PubMed | | | Data Table |  |
|
| 24 | [SID49649712] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 25 | [SID49649712] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 26 | [SID49649712] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|
| 27 | [SID49649712] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|
| 28 | [SID49649712] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 29 | [SID49649712] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 30 | [SID49649712] | Inactive | | | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS [AID485317, Type: screening] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS | | AID | 485317 | | BioAssay type | screening | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 31 | [SID49649712] | Inactive | Potency | | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 32 | [SID49649712] | Inactive | | | Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase [AID1556, Type: screening] | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase | | AID | 1556 | | BioAssay type | screening | | Target | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] | | PubMed | | | Data Table |  |
|
| 33 | [SID49649712] | Inactive | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 34 | [SID49649712] | Inactive | | | A qHTS for Small Molecule Inhibitors of Shiga Toxin [AID2315, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | A qHTS for Small Molecule Inhibitors of Shiga Toxin | | AID | 2315 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 35 | [SID49649712] | Inactive | IC50 | | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. [AID1986, Type: confirmatory] | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. | | AID | 1986 | | BioAssay type | confirmatory | | Target | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] | | PubMed | | | Data Table |  |
|
| 36 | [SID49649712] | Inactive | Potency | | qHTS of Trypanosoma Brucei Inhibitors [AID624173, Type: confirmatory] | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Trypanosoma Brucei Inhibitors | | AID | 624173 | | BioAssay type | confirmatory | | Target | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] | | PubMed | | | Data Table |  |
|
| 37 | [SID49649712] | Inactive | | | Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System [AID2094, Type: screening] | Chain A, Crystal Structure Of The Apo Form Of Vibrio Harveyi Luxp Complexed With The Periplasmic Dom [gi:67463988] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System | | AID | 2094 | | BioAssay type | screening | | Target | Chain A, Crystal Structure Of The Apo Form Of Vibrio Harveyi Luxp Complexed With The Periplasmic Dom [gi:67463988] | | PubMed | | | Data Table |  |
|
| 38 | [SID49649712] | Inactive | | | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro) [AID1706, Type: screening] | 3C-like protease [Infectious bronchitis virus] [gi:73745819] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro) | | AID | 1706 | | BioAssay type | screening | | Target | 3C-like protease [Infectious bronchitis virus] [gi:73745819] | | PubMed | | | Data Table |  |
|
| 39 | [SID49649712] | Inactive | | | PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity [AID602405, Type: screening] | WlaI protein (PglD) [gi:75495260] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602405 | | BioAssay type | screening | | Target | WlaI protein (PglD) [gi:75495260] | | PubMed | | | Data Table |  |
|
| 40 | [SID49649712] | Inactive | | | Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide [AID687016, Type: screening] | UHRF1 gene product [Homo sapiens] [gi:115430235] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide | | AID | 687016 | | BioAssay type | screening | | Target | UHRF1 gene product [Homo sapiens] [gi:115430235] | | PubMed | | | Data Table |  |
|
| 41 | [SID49649712] | Inactive | Potency | | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 42 | [SID49649712] | Inactive | Potency | | qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent) [AID485294, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent) | | AID | 485294 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 43 | [SID49649712] | Inactive | | | Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) [AID1845, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) | | AID | 1845 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 44 | [SID49649712] | Inactive | | | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) [AID1800, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) | | AID | 1800 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 45 | [SID49649712] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID504803, Type: screening] | HTRA1 protein [gi:121945198] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 504803 | | BioAssay type | screening | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|
| 46 | [SID49649712] | Inactive | Potency | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 47 | [SID49649712] | Inactive | | | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay [AID602438, Type: screening] | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay | | AID | 602438 | | BioAssay type | screening | | Target | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] | | PubMed | | | Data Table |  |
|
| 48 | [SID49649712] | Inactive | Potency | | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 49 | [SID49649712] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set [AID588497, Type: Literature] | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | | AID | 588497 | | BioAssay type | Literature | | Target | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] | | PubMed | 16604538 | | Data Table |  |
|
| 50 | [SID49649712] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49649712 | | CID | 20885160 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table |  |
|